Advancing Treatment Frontiers: Radiofrequency Ablation for Small Renal Mass—Intermediate-Term Results
Our study aims to discern the immediate and intermediate-term oncological outcomes of the patients with small renal mass and who were surgically unfit or were having a bilateral tumor and underwent radiofrequency ablation (RFA) of the mass. We retrospectively and prospectively analyzed the status o...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Codon Publications
2023-10-01
|
Series: | Journal of Kidney Cancer and VHL |
Subjects: | |
Online Access: | https://jkcvhl.com/index.php/jkcvhl/article/view/303 |
_version_ | 1797648967151910912 |
---|---|
author | Rohit Kumar Singh Manav Gideon Rohan Rajendran Georgie Mathew Kannan Nair |
author_facet | Rohit Kumar Singh Manav Gideon Rohan Rajendran Georgie Mathew Kannan Nair |
author_sort | Rohit Kumar Singh |
collection | DOAJ |
description |
Our study aims to discern the immediate and intermediate-term oncological outcomes of the patients with small renal mass and who were surgically unfit or were having a bilateral tumor and underwent radiofrequency ablation (RFA) of the mass. We retrospectively and prospectively analyzed the status of the patients who were diagnosed to have small renal masses and were biopsy-proven renal cell carcinoma (RCC) cases, who underwent RFA at our institute from the year 2013 to 2022. Patients were followed-up for 3 years. Data regarding complications were analyzed for all patients who underwent renal RFA along with the 3-year recurrence-free survival (RFS) rate. A total of 28 patients were eligible for the study based on our inclusion and exclusion criteria. Their renal function was recorded. They underwent RFA and were followed-up for a period of 3 years for RFS. Four patients out of the total had immediate complications, out of which two developed a hematoma. Three-year-follow-ups showed six recurrences, overall having 78.6% RFS. Post-procedural renal function was stable as documented by Estimated glomerular filtration rate. Oncological results of RFA in patients with small renal masses who are surgically unfit are associated with a low risk of immediate and intermediate-term deterioration of renal function.
|
first_indexed | 2024-03-11T15:38:31Z |
format | Article |
id | doaj.art-c9bdb39a94ad4d54b4fa767fa6d1a117 |
institution | Directory Open Access Journal |
issn | 2203-5826 |
language | English |
last_indexed | 2024-03-11T15:38:31Z |
publishDate | 2023-10-01 |
publisher | Codon Publications |
record_format | Article |
series | Journal of Kidney Cancer and VHL |
spelling | doaj.art-c9bdb39a94ad4d54b4fa767fa6d1a1172023-10-26T13:12:20ZengCodon PublicationsJournal of Kidney Cancer and VHL2203-58262023-10-0110410.15586/jkcvhl.v10i4.303Advancing Treatment Frontiers: Radiofrequency Ablation for Small Renal Mass—Intermediate-Term ResultsRohit Kumar Singh0Manav Gideon1Rohan Rajendran2Georgie Mathew3Kannan Nair4Department of Urology, Amrita Institute of Medical Sciences, Kochi, India.Mch Urology, Amrita Institute of Medical Sciences, Kochi, India.Department of Urology, Amrita Institute of Medical Sciences, Kochi, India.Department of Urology, Amrita Institute of Medical Sciences, Kochi, India.Department of Urology, Amrita Institute of Medical Sciences, Kochi, India. Our study aims to discern the immediate and intermediate-term oncological outcomes of the patients with small renal mass and who were surgically unfit or were having a bilateral tumor and underwent radiofrequency ablation (RFA) of the mass. We retrospectively and prospectively analyzed the status of the patients who were diagnosed to have small renal masses and were biopsy-proven renal cell carcinoma (RCC) cases, who underwent RFA at our institute from the year 2013 to 2022. Patients were followed-up for 3 years. Data regarding complications were analyzed for all patients who underwent renal RFA along with the 3-year recurrence-free survival (RFS) rate. A total of 28 patients were eligible for the study based on our inclusion and exclusion criteria. Their renal function was recorded. They underwent RFA and were followed-up for a period of 3 years for RFS. Four patients out of the total had immediate complications, out of which two developed a hematoma. Three-year-follow-ups showed six recurrences, overall having 78.6% RFS. Post-procedural renal function was stable as documented by Estimated glomerular filtration rate. Oncological results of RFA in patients with small renal masses who are surgically unfit are associated with a low risk of immediate and intermediate-term deterioration of renal function. https://jkcvhl.com/index.php/jkcvhl/article/view/303ablationcancerkidneyradiofrequencysmall renal mass |
spellingShingle | Rohit Kumar Singh Manav Gideon Rohan Rajendran Georgie Mathew Kannan Nair Advancing Treatment Frontiers: Radiofrequency Ablation for Small Renal Mass—Intermediate-Term Results Journal of Kidney Cancer and VHL ablation cancer kidney radiofrequency small renal mass |
title | Advancing Treatment Frontiers: Radiofrequency Ablation for Small Renal Mass—Intermediate-Term Results |
title_full | Advancing Treatment Frontiers: Radiofrequency Ablation for Small Renal Mass—Intermediate-Term Results |
title_fullStr | Advancing Treatment Frontiers: Radiofrequency Ablation for Small Renal Mass—Intermediate-Term Results |
title_full_unstemmed | Advancing Treatment Frontiers: Radiofrequency Ablation for Small Renal Mass—Intermediate-Term Results |
title_short | Advancing Treatment Frontiers: Radiofrequency Ablation for Small Renal Mass—Intermediate-Term Results |
title_sort | advancing treatment frontiers radiofrequency ablation for small renal mass intermediate term results |
topic | ablation cancer kidney radiofrequency small renal mass |
url | https://jkcvhl.com/index.php/jkcvhl/article/view/303 |
work_keys_str_mv | AT rohitkumarsingh advancingtreatmentfrontiersradiofrequencyablationforsmallrenalmassintermediatetermresults AT manavgideon advancingtreatmentfrontiersradiofrequencyablationforsmallrenalmassintermediatetermresults AT rohanrajendran advancingtreatmentfrontiersradiofrequencyablationforsmallrenalmassintermediatetermresults AT georgiemathew advancingtreatmentfrontiersradiofrequencyablationforsmallrenalmassintermediatetermresults AT kannannair advancingtreatmentfrontiersradiofrequencyablationforsmallrenalmassintermediatetermresults |